来自MSN2 天
Bristol Myers announces FDA approval of Opdivo Qvantig injection
Squibb announced that the U.S. FDA granted approval for Opdivo Qvantig injection for subcutaneous use, a combination product ...
Bristol-Myers Squibb : FDA Approves Opdivo Qvantig For Subcutaneous Use In Adult Solid Tumors
Bristol Myers Squibb (BMY) announced Friday that the U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and ...
Managed Healthcare Executive11 天
FDA Adds Boxed Warning to Veozah Label
The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
FDA alerting vets about arthritis drug after hundreds of reports of health problems in dogs
The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...
FiercePharma13 天
FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio
The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).
Managed Healthcare Executive5 天
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
FDA alerting veterinarians after reports of health problems in dogs tied to arthritis drug
Channel 2 Action News has learned that the FDA is now alerting veterinarians about reports of health problems in dogs – ...
dermatologyadvisor2 天
FDA Expands Approval of Vtama to Include Atopic Dermatitis
The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...
FDA Issues Vet Letter on Drug Librela Used to Control Pain in Dogs
The FDA's Center for Veterinary Medicine posted a letter alerting veterinarians of adverse health effects in dogs from ...
BioSpace9 天
Ionis’ Tryngolza Becomes First FDA-Approved Therapy for Familial Chylomicronemia Syndrome
Despite securing the industry’s first approval for familial chylomicronemia syndrome, BMO Capital Markets believes that ...